Trevi Therapeutics, Inc. TRVI Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s accrued liabilities, current?
- Trevi Therapeutics, Inc. (TRVI) reported accrued liabilities, current of $4.58M in Q1 2026.
- How has Trevi Therapeutics, Inc.'s accrued liabilities, current changed year-over-year?
- Trevi Therapeutics, Inc.'s accrued liabilities, current decreased by 11.4% year-over-year, from $5.17M to $4.58M.
- What is the long-term trend for Trevi Therapeutics, Inc.'s accrued liabilities, current?
- Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s accrued liabilities, current has grown at a 10.1% compound annual growth rate (CAGR), from $3.43M to $5.53M.